Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Journal of Cancer Research and Clinical Oncology|January 10, 2016
Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemiaMohamed El Missiry, Shady Adnan Awad, Hanna L Rajala, et al.
Blood|July 12, 2013
Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registryMartin Höglund, Fredrik Sandin, Karin Hellström, et al.
Leukemia|November 3, 2023
Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuationJani Huuhtanen, Shady Adnan-Awad, Jason Theodoropoulos, et al.
European Journal of Haematology|August 2, 2014
Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)Henrik Hjorth-Hansen, Leif Stenke, Stina Söderlund, et al.
Leukemia|January 26, 2024
Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trialHjalmar Flygt, Stina Söderlund, Johan Richter, et al.
Leukemia|June 24, 2020
Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND studyAndreas Hochhaus, Carlo Gambacorti-Passerini, Camille Abboud, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|December 1, 2004
Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survivalUlla Olsson-Strömberg, Bengt Simonsson, Tomas Ahlgren, et al.
American Journal of Hematology|August 29, 2019
Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobinMichael Lauseker, Katharina Bachl, Anna Turkina, et al.
Leukemia|September 16, 2025
Granulocyte abundance and maturation state at diagnosis predicts treatment-free remission in CMLMikko Purhonen, Mikael Tatun, Katariina Luukkainen, et al.
Nature Medicine|May 16, 2017
Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemiaAlice Giustacchini, Supat Thongjuea, Nikolaos Barkas, et al.
Pageof 5